BCHi024-A-1

HNDS0142-01#D CNC11(+/-)

General

Cell Line

hPSCreg name BCHi024-A-1
Cite as:
BCHi024-A-1
Alternative name(s)
HNDS0142-01#D CNC11(+/-)
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
BCHi024-A-2
(HNDS0142-01#D CC45-6(+/+))
Donor diseases:
Haploinsufficiency
BCHi024-A
(HNDS0142-01#D)
Donor diseases:
Haploinsufficiency
BCHi022-A-1
(HNDS0108-01#B CNC7(+/-))
Donor diseases:
Haploinsufficiency
BCHi022-A-2
(HNDS0108-01#B CC5(+/+))
Donor diseases:
Haploinsufficiency
BCHi023-A-1
(HNDS0105-01#B CNC5(+/-))
Donor diseases:
Haploinsufficiency
BCHi023-A-2
(HNDS0105-01#B CC28(+/+))
Donor diseases:
Haploinsufficiency
BCHi025-A-1
(HNDS0140-01#C CNC30(+/-))
Donor diseases:
Haploinsufficiency
BCHi025-A-2
(HNDS0140-01#C CC8(+/+))
Donor diseases:
Haploinsufficiency
BCHi022-A
(HNDS0108-01#B)
Donor diseases:
Haploinsufficiency
BCHi023-A
(HNDS0105-01#B)
Donor diseases:
Haploinsufficiency
BCHi025-A
(HNDS0140-01#C)
Donor diseases:
Haploinsufficiency
Last update 2nd March 2024
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Children's Hospital (BCH)

External Databases

BioSamples SAMEA115372017

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex male
Ethnicity White, English

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is affected.

Karyotyping (Donor)

Has the donor karyotype been analysed?
No

External Databases (Donor)

BioSamples SAMEA115372006

Ethics

Also have a look at the ethics information for the parental line BCHi024-A .
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line BCHi024-A.

Reprogramming method

Vector type Non-integrating
Vector Sendai virus

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Other medium:
Base medium: Stemflex
Main protein source: Bovine Serum Albumin (BSA)
Serum concentration: 1 %
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

No characterisation data could be found for this subclone. Please open parental cell line BCHi024-A .

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46, XY; no clonal abnormalities
Karyotyping method: G-Banding

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Genetic modifications
SETBP1 (target)
Variant
cytoband location: 18q12.3
NM_015559.3: c.1568delA, p.H523LfsX32
Heterozygous